Hims & Hers Health Class A (HIMS) closed at $26.00 on November 6, 2026, up 8.1% from the previous close, on volume of 11,485,468 shares (30-day average 9,402,301).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts | Position |
|---|---|---|---|---|---|
| 1 | Oct 23, 2026 | Call Spread | 30-Oct-2628.5 : 30 C | 17,018 | |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | ||||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Earnings Week Ahead: CSCO, CRWV, PLUG, ALC, AMAT, ACB, RKLB, ASTS, and more
Seeking Alpha News (Sun, 8-Nov 8:07 AM ET)
Earnings Scorecard: 96% healthcare firms post EPS wins this week
Seeking Alpha News (Sat, 7-Nov 10:40 AM ET)
TipRanks (Fri, 6-Nov 3:30 PM ET)
Polymarket Odds: Will RKLB, HIMS, TTD Beat Earnings on Monday?
TipRanks (Fri, 6-Nov 1:50 PM ET)
Hims & Hers Stock Jumps Ahead of Q3 Earnings on Nov. 9 — Here’s Why
TipRanks (Fri, 6-Nov 11:53 AM ET)
Hims & Hers Stock Jumps Ahead of Q3 Earnings — Here’s Why
TipRanks (Fri, 6-Nov 11:53 AM ET)
Hims & Hers gains on partnership with Eli Lilly
Seeking Alpha News (Fri, 6-Nov 7:35 AM ET)
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
Business Wire (Fri, 6-Nov 6:47 AM ET)
Hims & Hers Health Q3 Earnings Are on Nov. 9 – Options Traders Expect a Large Move in HIMS Stock
TipRanks (Thu, 5-Nov 11:17 PM ET)
Globe Newswire (Thu, 5-Nov 9:20 AM ET)
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Hims & Hers Health Class A trades on the NYSE stock market under the symbol HIMS.
As of November 6, 2026, HIMS stock price climbed to $26.00 with 11,485,468 million shares trading.
HIMS has a beta of 2.66, meaning it tends to be more sensitive to market movements. HIMS has a correlation of 0.12 to the broad based SPY ETF.
HIMS has a market cap of $6.07 billion. This is considered a Mid Cap stock.
Last quarter Hims & Hers Health Class A reported $753 million in Revenue and -$.37 earnings per share. This beat revenue expectation by $31 million and missed earnings estimates by -$.32.
In the last 3 years, HIMS traded as high as $72.98 and as low as $6.58.
The top ETF exchange traded funds that HIMS belongs to (by Net Assets): VTI, IJH, VB, IWM, VBK.
HIMS has underperformed the market in the last year with a price return of -37.4% while the SPY ETF gained +10.8%. HIMS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.3% and -6.2%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
HIMS support price is $22.72 and resistance is $25.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HIMS shares will trade within this expected range on the day.
